BIOECLIPSE THERAPEUTICS

bioeclipse-therapeutics-logo

BioEclipse Therapeutics is a clinical-stage oncology company that develops immuno-oncology therapeutics using its proprietary technology. Its mission is to improve clinical outcomes and the quality of life for all cancer patients and to be at the forefront of turning cancer into a curable disease. The company has harnessed a refined understanding of the human immune system, gaining insights into the reasons the body’s defense system so often turns a blind eye to the presence of cancerous cells and tumors. In response, BioEclipse Therapeutics pairs activated immune cells with an adapted oncolytic virus that selectively infects and kills malignant cells.

#SimilarOrganizations #People #Financial #Event #Website #More

BIOECLIPSE THERAPEUTICS

Social Links:

Industry:
Biotechnology Health Care Therapeutics

Founded:
2006-01-01

Address:
San Francisco, California, United States

Country:
United States

Website Url:
http://www.bioeclipse.com

Total Employee:
1+

Status:
Active

Contact:
(408)809-1030

Email Addresses:
[email protected]

Total Funding:
15.7 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress


Similar Organizations

aimmune-therapeutics-logo

Aimmune Therapeutics

Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.

apellis-pharmaceuticals-logo

Apellis Pharmaceuticals

Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.

ribon-therapeutics-logo

Ribon Therapeutics

Ribon Therapeutics is a biotechnology company focused on the development of therapeutics treatments targeting stress support pathways.


Current Advisors List

mahmoud-mahmoudian_image

Mahmoud Mahmoudian Board of Directors @ BioEclipse Therapeutics
Board_member
2022-01-01

pamela-contag_image

Pamela Contag Board Director @ BioEclipse Therapeutics
Board_member

elona-baum_image

Elona Baum Board Member @ BioEclipse Therapeutics
Board_member

not_available_image

Mark Frohlich Board Member @ BioEclipse Therapeutics
Board_member

oliver-hopkinson_image

Oliver Hopkinson Board Member @ BioEclipse Therapeutics
Board_member

chris-contag_image

Chris Contag Scientific Advisor @ BioEclipse Therapeutics
Advisor

robert-negrin_image

Robert Negrin Scientific Advisor @ BioEclipse Therapeutics
Advisor

Current Employees Featured

robert-negrin_image

Robert Negrin
Robert Negrin Co-Founder @ BioEclipse Therapeutics
Co-Founder

stephen-ghiglieri_image

Stephen Ghiglieri
Stephen Ghiglieri Interim CFO @ BioEclipse Therapeutics
Interim CFO
2022-01-01

pamela-contag_image

Pamela Contag
Pamela Contag CEO and Founder @ BioEclipse Therapeutics
CEO and Founder
2016-08-01

chris-contag_image

Chris Contag
Chris Contag Co-Founder @ BioEclipse Therapeutics
Co-Founder

benjamin-carter_image

Benjamin Carter
Benjamin Carter Chief Financial Officer @ BioEclipse Therapeutics
Chief Financial Officer
2016-01-01

Founder


chris-contag_image

Chris Contag

pamela-contag_image

Pamela Contag

robert-negrin_image

Robert Negrin

Investors List

california-institute-of-regenerative-medicine-cirm_image

California Institute of Regenerative Medicine (CIRM)

California Institute of Regenerative Medicine (CIRM) investment in Grant - BioEclipse Therapeutics

defta-partners_image

DEFTA Partners

DEFTA Partners investment in Series A - BioEclipse Therapeutics

plum-alley-co_image

Plum Alley Investments

Plum Alley Investments investment in Series A - BioEclipse Therapeutics

tsingyuan-ventures_image

Foothill Ventures

Foothill Ventures investment in Series A - BioEclipse Therapeutics

revelis-capital-group_image

Revelis Capital Group

Revelis Capital Group investment in Series A - BioEclipse Therapeutics

tsvcap_image

TSVC

TSVC investment in Series A - BioEclipse Therapeutics

plum-alley-co_image

Plum Alley Investments

Plum Alley Investments investment in Seed Round - BioEclipse Therapeutics

tsvcap_image

TSVC

TSVC investment in Venture Round - BioEclipse Therapeutics

Key Employee Changes

Date New article
2022-01-26 BioEclipse Therapeutics Appoints New Board Member and Names Interim CFO

Official Site Inspections

http://www.bioeclipse.com Semrush global rank: 5.74 M Semrush visits lastest month: 1.46 K

  • Host name: hwsrv-208397.hostwindsdns.com
  • IP address: 23.254.161.11
  • Location: Seattle United States
  • Latitude: 47.4902
  • Longitude: -122.3004
  • Metro Code: 819
  • Timezone: America/Los_Angeles
  • Postal: 98168

Loading ...

More informations about "BioEclipse Therapeutics"

About Us - BioEclipse

BioEclipse Therapeuticsâ„¢ is a clinical-stage oncology company that uses its proprietary platform technology to develop the next generation of immuno-oncology therapeutics. Foundationally, …See details»

BioEclipse Therapeutics™ | NEXT GENERATION OF …

The BioEclipse Solution . Our team is bringing treatment options to cancer patients with resistant and recurring solid tumors with the mission of eradicating primary disease while generating a lasting tumor-specific immune response. …See details»

BioEclipse Therapeutics - Crunchbase Company Profile …

BioEclipse Therapeutics conducts Phase 1 clinical trials to evaluate the safety, tolerability, and efficacy of CRX100 in participants with advanced solid tumors. …See details»

BioEclipse Therapeutics, Inc | LinkedIn

BioEclipse Therapeuticsâ„¢ is a clinical-stage oncology company developing a new generation of precise, targeted, immunotherapies that bring hope to patients with advanced cancer who have few ...See details»

Pamela Contag - BioEclipse Therapeutics, Inc - LinkedIn

I am CEO of BioEclipse (www.bioeclipse.com). Our team has raised funding in order to… · Experience: BioEclipse Therapeutics, Inc · Location: San Jose · 500+ connections on …See details»

BioEclipse Therapeutics, Inc. - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for BioEclipse Therapeutics, Inc. of Mountain View, CA. Get the latest business insights from Dun & Bradstreet.See details»

BIoEclipse Therapeutics - Craft

BIoEclipse Therapeutics is a biopharmaceutical company developing curative immuno-oncology therapeutics to patients with cancer. Its technology safely activates a patient’s own immune …See details»

BioEclipse Therapeutics - Org Chart, Teams, Culture & Jobs - The …

View BioEclipse Therapeutics' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more. This is an unverified …See details»

BioEclipse Therapeutics™ | BioEclipse Therapeutics™ Announces …

Mountain View, CA – May 19, 2020 – BioEclipse Therapeuticsâ„¢ (BioEclipse), a private clinical-stage biopharmaceutical company committed to developing first-in-class, curative immuno …See details»

Bioeclipse Therapeutics (USA) Funding: $15.7M

BioEclipse Therapeutics is a clinical-stage oncology company that develops immuno-oncology therapeutics using its proprietary... Menu BY DISEASE BY TECHNOLOGY BY COUNTRY. …See details»

Bioeclipse Therapeutics - VentureRadar

BioEclipse Therapeutics is an emerging, clinical-stage biopharmaceutical company committed to delivering first-in-class, curative immuno-oncology therapeutics to patients with cancer. Our …See details»

BioEclipse Therapeutics - Contacts, Employees, Board Members, …

BioEclipse Therapeutics is a clinical-stage oncology company that develops immuno-oncology therapeutics using its proprietary technology. ... Experience the new Crunchbase, powered by …See details»

Jobs at BioEclipse Therapeutics | Foothill Ventures

BioEclipse Therapeuticsâ„¢ is a clinical-stage oncology company that uses its proprietary technology to develop the next generation of immuno-oncology therapeutics. Foundationally, …See details»

BioEclipse Therapeutics - Funding, Financials, Valuation & Investors

How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors ... Seed Round - BioEclipse …See details»

BioEclipse Therapeutics™ Awarded Grant to Fund Cancer …

Apr 26, 2022 MOUNTAIN VIEW, Calif., April 26, 2022 /PRNewswire/ -- BioEclipse Therapeuticsâ„¢ (BioEclipse), a privately held, clinical-stage biopharmaceutical company with a …See details»

BioEclipse Therapeutics™ | BioEclipse Therapeutics Appoints New …

Jan 26, 2022 BioEclipse Therapeuticsâ„¢ is an emerging, clinical-stage biopharmaceutical company using a novel platform that combines immune cells and an oncolytic virus to expand …See details»

BioEclipse Therapeutics Announces First Patient Dosed in

Mountain View, Calif., March 5, 2021 --BioEclipse Therapeuticsâ„¢ (BioEclipse), a private clinical-stage biopharmaceutical company with a proprietary platform for developing next-generation …See details»

‘A living collective’: study shows trees synchronise electrical signals ...

Apr 29, 2025 A solar eclipse occurs when the Moon passes between the Sun and Earth, fully or partially blocking the Sun’s light. An eclipse can inspire awe and even social cohesion in …See details»

BioEclipse Therapeuticsâ„¢ | BioEclipse Therapeuticsâ„¢ Announces ...

Jun 24, 2019 BioEclipse Therapeutics is an emerging, clinical-stage biopharmaceutical company committed to delivering first-in-class, curative immuno-oncology therapeutics to patients with …See details»

BioEclipse Therapeuticsâ„¢ | News

Sep 25, 2020 BioEclipse Therapeutics CEO, Dr. Pamela Contag, is named in Top 50 Women Leaders of San Jose for 2024 by "Women We Admire" magazine. In San Jose, it’s all about …See details»

linkstock.net © 2022. All rights reserved